vs
DIGI INTERNATIONAL INC（DGII）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Ultragenyx Pharmaceutical Inc.的季度营收约是DIGI INTERNATIONAL INC的1.7倍（$207.3M vs $122.5M），DIGI INTERNATIONAL INC净利率更高（9.6% vs -62.0%，领先71.6%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 17.9%），DIGI INTERNATIONAL INC自由现金流更多（$35.2M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 6.6%）
Digi International Inc.是总部位于美国明尼苏达州霍普金斯的工业物联网（IIoT）科技企业，成立于1985年。上世纪90年代初，该公司以生产多线路串行数据卡闻名，可支持兼容机运行多线路公告板系统（BBS）。90年代末互联网兴起后，公司逐步转向网络接入设备与工业监测领域布局。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
DGII vs RARE — 直观对比
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $122.5M | $207.3M |
| 净利润 | $11.7M | $-128.6M |
| 毛利率 | 62.4% | — |
| 营业利润率 | 13.3% | -54.7% |
| 净利率 | 9.6% | -62.0% |
| 营收同比 | 17.9% | 25.9% |
| 净利润同比 | 16.1% | 3.5% |
| 每股收益（稀释后） | $0.31 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $122.5M | $207.3M | ||
| Q3 25 | $114.3M | $159.9M | ||
| Q2 25 | $107.5M | $166.5M | ||
| Q1 25 | $104.5M | $139.3M | ||
| Q4 24 | $103.9M | $164.6M | ||
| Q3 24 | $105.1M | $139.5M | ||
| Q2 24 | $105.2M | $147.0M | ||
| Q1 24 | $107.7M | $108.8M |
| Q4 25 | $11.7M | $-128.6M | ||
| Q3 25 | $10.0M | $-180.4M | ||
| Q2 25 | $10.2M | $-115.0M | ||
| Q1 25 | $10.5M | $-151.1M | ||
| Q4 24 | $10.1M | $-133.2M | ||
| Q3 24 | $11.9M | $-133.5M | ||
| Q2 24 | $9.7M | $-131.6M | ||
| Q1 24 | $4.0M | $-170.7M |
| Q4 25 | 62.4% | — | ||
| Q3 25 | 63.9% | — | ||
| Q2 25 | 63.5% | — | ||
| Q1 25 | 62.1% | — | ||
| Q4 24 | 62.0% | — | ||
| Q3 24 | 61.1% | — | ||
| Q2 24 | 59.2% | — | ||
| Q1 24 | 57.9% | — |
| Q4 25 | 13.3% | -54.7% | ||
| Q3 25 | 12.5% | -106.9% | ||
| Q2 25 | 13.9% | -64.8% | ||
| Q1 25 | 13.1% | -102.6% | ||
| Q4 24 | 12.9% | -74.3% | ||
| Q3 24 | 14.2% | -94.6% | ||
| Q2 24 | 12.3% | -79.1% | ||
| Q1 24 | 7.6% | -151.9% |
| Q4 25 | 9.6% | -62.0% | ||
| Q3 25 | 8.7% | -112.8% | ||
| Q2 25 | 9.5% | -69.0% | ||
| Q1 25 | 10.0% | -108.5% | ||
| Q4 24 | 9.7% | -80.9% | ||
| Q3 24 | 11.3% | -95.7% | ||
| Q2 24 | 9.2% | -89.5% | ||
| Q1 24 | 3.7% | -156.8% |
| Q4 25 | $0.31 | $-1.28 | ||
| Q3 25 | $0.26 | $-1.81 | ||
| Q2 25 | $0.27 | $-1.17 | ||
| Q1 25 | $0.28 | $-1.57 | ||
| Q4 24 | $0.27 | $-1.34 | ||
| Q3 24 | $0.32 | $-1.40 | ||
| Q2 24 | $0.26 | $-1.52 | ||
| Q1 24 | $0.11 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $30.9M | $421.0M |
| 总债务越低越好 | $135.0M | — |
| 股东权益账面价值 | $649.2M | $-80.0M |
| 总资产 | $918.4M | $1.5B |
| 负债/权益比越低杠杆越低 | 0.21× | — |
8季度趋势，按日历期对齐
| Q4 25 | $30.9M | $421.0M | ||
| Q3 25 | $21.9M | $202.5M | ||
| Q2 25 | $20.1M | $176.3M | ||
| Q1 25 | $26.3M | $127.1M | ||
| Q4 24 | $25.9M | $174.0M | ||
| Q3 24 | $27.5M | $150.6M | ||
| Q2 24 | $28.3M | $480.7M | ||
| Q1 24 | $23.8M | $112.3M |
| Q4 25 | $135.0M | — | ||
| Q3 25 | $159.2M | — | ||
| Q2 25 | $40.1M | — | ||
| Q1 25 | $70.0M | — | ||
| Q4 24 | $95.0M | — | ||
| Q3 24 | $123.2M | — | ||
| Q2 24 | $151.6M | — | ||
| Q1 24 | $171.8M | — |
| Q4 25 | $649.2M | $-80.0M | ||
| Q3 25 | $636.1M | $9.2M | ||
| Q2 25 | $621.5M | $151.3M | ||
| Q1 25 | $605.2M | $144.2M | ||
| Q4 24 | $590.7M | $255.0M | ||
| Q3 24 | $581.0M | $346.8M | ||
| Q2 24 | $563.1M | $432.4M | ||
| Q1 24 | $549.6M | $140.3M |
| Q4 25 | $918.4M | $1.5B | ||
| Q3 25 | $922.6M | $1.2B | ||
| Q2 25 | $770.3M | $1.3B | ||
| Q1 25 | $781.0M | $1.3B | ||
| Q4 24 | $796.1M | $1.5B | ||
| Q3 24 | $815.1M | $1.5B | ||
| Q2 24 | $820.4M | $1.6B | ||
| Q1 24 | $825.3M | $1.3B |
| Q4 25 | 0.21× | — | ||
| Q3 25 | 0.25× | — | ||
| Q2 25 | 0.06× | — | ||
| Q1 25 | 0.12× | — | ||
| Q4 24 | 0.16× | — | ||
| Q3 24 | 0.21× | — | ||
| Q2 24 | 0.27× | — | ||
| Q1 24 | 0.31× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $35.6M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $35.2M | $-100.8M |
| 自由现金流率自由现金流/营收 | 28.7% | -48.6% |
| 资本支出强度资本支出/营收 | 0.4% | 0.5% |
| 现金转化率经营现金流/净利润 | 3.04× | — |
| 过去12个月自由现金流最近4个季度 | $111.4M | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | $35.6M | $-99.8M | ||
| Q3 25 | $28.0M | $-91.4M | ||
| Q2 25 | $24.0M | $-108.3M | ||
| Q1 25 | $26.3M | $-166.5M | ||
| Q4 24 | $29.7M | $-79.3M | ||
| Q3 24 | $26.4M | $-67.0M | ||
| Q2 24 | $24.9M | $-77.0M | ||
| Q1 24 | $13.1M | $-190.7M |
| Q4 25 | $35.2M | $-100.8M | ||
| Q3 25 | $27.5M | $-92.7M | ||
| Q2 25 | $22.9M | $-110.7M | ||
| Q1 25 | $25.7M | $-167.8M | ||
| Q4 24 | $29.1M | $-79.5M | ||
| Q3 24 | $25.5M | $-68.6M | ||
| Q2 24 | $24.5M | $-79.0M | ||
| Q1 24 | $12.5M | $-193.9M |
| Q4 25 | 28.7% | -48.6% | ||
| Q3 25 | 24.1% | -58.0% | ||
| Q2 25 | 21.3% | -66.5% | ||
| Q1 25 | 24.6% | -120.5% | ||
| Q4 24 | 28.1% | -48.3% | ||
| Q3 24 | 24.3% | -49.2% | ||
| Q2 24 | 23.2% | -53.7% | ||
| Q1 24 | 11.6% | -178.2% |
| Q4 25 | 0.4% | 0.5% | ||
| Q3 25 | 0.4% | 0.8% | ||
| Q2 25 | 0.9% | 1.5% | ||
| Q1 25 | 0.5% | 1.0% | ||
| Q4 24 | 0.6% | 0.1% | ||
| Q3 24 | 0.9% | 1.2% | ||
| Q2 24 | 0.5% | 1.4% | ||
| Q1 24 | 0.5% | 3.0% |
| Q4 25 | 3.04× | — | ||
| Q3 25 | 2.81× | — | ||
| Q2 25 | 2.34× | — | ||
| Q1 25 | 2.50× | — | ||
| Q4 24 | 2.95× | — | ||
| Q3 24 | 2.23× | — | ||
| Q2 24 | 2.57× | — | ||
| Q1 24 | 3.27× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DGII
| Io T Productsand Services | $86.4M | 71% |
| Io T Solutions | $36.1M | 29% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
